mRNA |
NVP-BEZ235 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
0.002 |
mRNA |
PRIMA-1-Met |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.002 |
mRNA |
AZD8055 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.002 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.002 |
mRNA |
SR-II-138A |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
Camptothecin |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.003 |
mRNA |
MK-2206 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.003 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.003 |
mRNA |
Talazoparib |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.003 |